Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
receptor like tyrosine kinase | 0.705 | 0.423 | 0.99 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1996 | 1996 | ||||||||
|
folate receptor alpha | 0.522 | 0.885 | 0.13 |
|
disease | 0.060 | None | 1.000 | 6 | 0 | 1997 | 2019 | ||||||||
|
colony stimulating factor 1 | 0.473 | 0.808 | 1.00 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1997 | 2009 | ||||||||
|
colony stimulating factor 1 receptor | 0.448 | 0.808 | 0.13 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2009 | ||||||||
|
colony stimulating factor 2 | 0.330 | 0.962 | 0.83 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1997 | 2009 | ||||||||
|
angiogenin | 0.511 | 0.769 | 0.29 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1997 | 1997 | ||||||||
|
hematopoietic prostaglandin D synthase | 0.388 | 0.923 | 1.8E-06 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1998 | 2006 | ||||||||
|
BCL2 associated X, apoptosis regulator | 0.417 | 0.885 | 0.32 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1998 | 2016 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
disease | 0.100 | None | 0.947 | 38 | 1 | 1999 | 2020 | ||||||||
|
BCL2 apoptosis regulator | 0.291 | 0.885 | 0.56 |
|
disease | 0.100 | None | 1.000 | 15 | 0 | 1999 | 2019 | ||||||||
|
epidermal growth factor | 0.357 | 0.923 | 8.5E-17 |
|
disease | 0.100 | None | 0.900 | 10 | 0 | 1999 | 2019 | ||||||||
|
mutL homolog 1 | 0.399 | 0.808 | 3.4E-05 |
|
disease | 0.070 | None | 1.000 | 7 | 0 | 1999 | 2013 | ||||||||
|
cyclin dependent kinase inhibitor 1A | 0.403 | 0.769 | 1.9E-03 |
|
disease | 0.050 | None | 1.000 | 5 | 0 | 1999 | 2004 | ||||||||
|
thymidine phosphorylase | 0.495 | 0.769 | 1.2E-04 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2000 | ||||||||
|
cyclin D1 | 0.344 | 0.923 | 0.89 |
|
disease | 0.230 | None | 1.000 | 3 | 0 | 1999 | 2017 | ||||||||
|
synthesis of cytochrome C oxidase 2 | 0.479 | 0.846 | 7.5E-07 |
|
disease | 0.030 | None | 1.000 | 3 | 0 | 1999 | 2000 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
disease | 0.020 | None | 1.000 | 2 | 0 | 1999 | 2014 | ||||||||
|
solute carrier organic anion transporter family member 6A1 | 0.412 | 0.885 | 2.9E-11 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
fragile site, aphidicolin type, common, fra(7)(q31.2) | 0.695 | 0.462 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | |||||||||
|
glutathione S-transferase kappa 1 | 0.412 | 0.885 | 1.9E-06 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
secreted protein acidic and cysteine rich | 0.445 | 0.846 | 0.89 |
|
disease | 0.010 | None | 1.000 | 1 | 0 | 1999 | 1999 | ||||||||
|
insulin like growth factor 2 | 0.390 | 0.885 | 4.4E-02 |
|
disease | 0.100 | None | 0.909 | 11 | 0 | 2000 | 2019 | ||||||||
|
androgen receptor | 0.351 | 0.846 | 0.99 |
|
disease | 0.090 | None | 1.000 | 9 | 0 | 2000 | 2019 | ||||||||
|
C-X-C motif chemokine ligand 8 | 0.310 | 0.962 | 2.7E-04 |
|
disease | 0.080 | None | 0.875 | 8 | 0 | 2000 | 2017 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
disease | 0.080 | None | 1.000 | 8 | 0 | 2000 | 2019 |